Literature DB >> 6571835

Reversal of thrombin-induced myosin phosphorylation and the assembly of cytoskeletal structures in platelets by the adenylate cyclase stimulants prostaglandin D2 and forskolin.

M B Feinstein, J J Egan, E E Opas.   

Abstract

Stimulation of platelets by thrombin causes an increase in the amount of cytoskeleton proteins insoluble in 1% Triton X-100, i.e. myosin, actin, actin-binding protein, an alpha-actinin-like protein of Mr = 105,000, unidentified polypeptides of Mr = 150,000, 31,00, and under some conditions, 56,000. Concurrently the Mr = 20,000 light chains of myosin and a cytoplasmic Mr = 42,000 polypeptide are phosphorylated, presumably by calmodulin-Ca2+-dependent myosin light chain kinase and a phospholipid-Ca2+-dependent kinase, respectively. The adenylate cyclase stimulators prostaglandin D2 (PGD2) and forskolin increased platelet cyclic AMP and prevented the phosphorylation of these polypeptides and the increase in Triton-insoluble cytoskeleton proteins. When added to platelets after stimulation by thrombin they caused rapid complete reversal of myosin light chain and Mr = 42,000 polypeptide phosphorylation; simultaneously the association of myosin with the cytoskeleton proteins and the increase in the content of each of the Triton-insoluble cytoskeleton proteins (except the Mr = 56,000 polypeptide) was reversed. The amount of Triton-insoluble myosin was affected more readily by PGD2 or forskolin than were the other proteins. Increasing thrombin from 0.1 to 1.0 unit/ml inhibited all the responses to PGD2 and forskolin possibly due to concentration-dependent effects of thrombin that inhibit adenylate cyclase. These results suggest that cytoskeleton assembly and activation of the contractile apparatus in intact platelets are readily reversible by cyclic AMP-dependent reactions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6571835

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Activation of signal transduction in platelets by the tyrosine phosphatase inhibitor pervanadate (vanadyl hydroperoxide).

Authors:  K M Pumiglia; L F Lau; C K Huang; S Burroughs; M B Feinstein
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

2.  Prostacyclin inhibits platelet aggregation induced by phorbol ester or Ca2+ ionophore at steps distal to activation of protein kinase C and Ca2+-dependent protein kinases.

Authors:  W Siess; E G Lapetina
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

3.  Different responsiveness of prostaglandin D2-sensitive systems to prostaglandin D2 and its analogues.

Authors:  S Narumiya; N Toda
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

4.  Reciprocal transmembranous receptor-cytoskeleton interactions in concanavalin A-activated platelets.

Authors:  M E Wheeler; J M Gerrard; R C Carroll
Journal:  J Cell Biol       Date:  1985-09       Impact factor: 10.539

5.  Actin filament content and organization in unstimulated platelets.

Authors:  J E Fox; J K Boyles; C C Reynolds; D R Phillips
Journal:  J Cell Biol       Date:  1984-06       Impact factor: 10.539

6.  Recycling of platelet phosphorylation and cytoskeletal assembly.

Authors:  A C Cox; R C Carroll; J G White; G H Rao
Journal:  J Cell Biol       Date:  1984-01       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.